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The 220 kDa fl-subunit of erythroid cell spectrin is a potent inhibitor of protein synthesis in lysates from 
rabbit reticulocytes. On the basis of weight of protein added to a lysate reaction mixture, it has about half 
the inhibitory activity of highly purified heme-regulated eIF-2% kinase. Inhibition appears to be at the level 
of peptide initiation but does not involve a kinase that phosphorylat~ eIF-2 on its a-subunit. 
jL!Spectrin Peptide initiation Protein synthesis 
1. I~R~DUCTION 
The cytoskeleton of eukaryotic cells is thought 
to play an important role in protein synthesis and 
its regtdation [l-3]. In erythroid cells heterodimers 
of the m- and fl-subunits of spectrin form the 
cytoskeleton or membrane skeleton in erythroid 
cells. Membrane-associated proteins that are struc- 
turally closely related to erythroid spectrin have 
been identified in a variety of other cell types 
(review ]4]). Partial amino acid sequences of the 
subunits of human erythrocyte spectrin have been 
determined irectly IS]; recently the DNA sequence 
of mouse nonerythroid cz-spectrin has been 
published [a]. Strong homologies in amino acid se- 
quence and structure are apparent between the LY- 
and &subunits. Both appear to be comprised of 
similar l~amino-acid repeating units. However, 
other unique characteristics distinguish the a’- and 
,%spectrin peptides. The latter contains the 
ankyrin-binding site [4]. The threonine and 3 
serine residues at which spectrin is phosphorylated 
are located within a 20 kDa segment at the 
carboxyl-terminal end of this peptide 171. Recently, 
* To whom correspondence should be addressed 
~~~reviations~ poiy(U), polyuridylic acid; PMSF, 
p~enylmethylsu~fonyl fluoride; eIF-2, eukaryotic initia- 
tion factor 2; DTT, dithiothreitol 
we presented evidence indicating that the 90 kDa 
component of the heme-controlled kinase from 
rabbit reticulocytes that phosphorylates the 
smallest or a-subunit of eIF-2 is structurally 
related to and probably derived by proteolysis 
from the C-terminal region of &spectrin [8]. Here 
we demonstrate that ,&spectrin, but not the (a,,@ 
heterodimer, is a potent inhibitor of protein syn- 
thesis in reticulocyte lysates. The mechanism ap- 
pears to involve peptide initiation but not a kinase 
that phosphorylates eIF-2 on its a;subunit. 
2. MATERIALS AND METHODS 
2.1. Materials 
Hydroxyapatite and edeine were purchased from 
Calbiochem, ]T-~P]ATP from New England 
NucIear and [“CJIeucine from ICN. 
2.2. Methods 
2.2.1. Isolation of fl-spectrin 
Spectrin was extracted from the membrane frac- 
tion of rabbit reticulocytes by the procedure of Lit- 
man et al. [9]. Spectrin was further purified and 
separated from regulin [ 101 by chromatography on 
DEAE-cellulose as outlined in [8]. In method 1, 
spectrin was batch-eluted from this column with 
KC1 between the levels of 200 and 400 mM in 
20 mM Tris-HCI (pH 8.3), 0.5 mM dithiothreitol, 
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1 mM EGTA, and 1 mM PMSF. The spectrin 
fraction was concentrated, dialyzed against 10 mM 
phosphate (pH 6.4), 0.5 mM dithiothreitol, 1 mM 
PMSF and 7 M urea, then applied to a hy- 
droxyapatite column equilibrated in the same solu- 
tion. Chromatography of spectrin on this matrix 
was carried out following the procedure of Calvert 
et al. ill]. Protein fractions eluting with 200 mM 
phosphate (pH 6.4) contained predominantly ,% 
spectrin. We estimate less than 10% contamination 
by cu-spectrin based on Coomassie blue staining of 
an SDS-polyacrylamide gel on which the peptides 
were analyzed. The fractions were concentrated, 
dialyzed extensively against 20 mM Tris-HCl (pH 
7.9, 50 mM KCl, 0.5 mM dithiothreitol, then 
stored in small aliquots at -80°C. 
In method 2, spectrin extracted from the mem- 
brane fraction was also chromatographed on 
DEAE-cellulose as described above. After concen- 
tration an aliquot of the spectrin fraction (about 
0.2 mg protein) was incubated for 10 min at 37°C 
with 5 pg casein kinase II [12] and 0.1 mM 
[T-~~P]ATP (about 8 Ci/mmol). Then the reaction 
mixture was loaded on a 10% polyacrylamide gel 
and electrophoresed under nondenaturing condi- 
tions. An autoradiogram was prepared from the 
wet gel immediately after electrophoresis, then the 
band corresponding to radioactive ,&spectrin was 
cut from the gel. The protein was elec- 
trophoretically eluted using a 7% disc gel in a BRL 
preparative gel electrophoresis apparatus. The pro- 
tein was collected between the bottom of this disc 
gel and a dialysis membrane attached to the lower 
end of the glass tube. The resulting,&spectrin frac- 
tion was stored in small aliquots at -80°C and 
was free of other peptides as judged by SDS- 
polyacrylamide gel electrophoresis and auto- 
radiography. 
2.2.2. Isolation of eIF-2 and the eIF-2cu kinase 
Purification of eIF-2 has been reported [ 131. The 
isolation procedure for the protein kinase has been 
outlined in [S] and will be described in detail 
elsewhere. 
2.2.3. Enzyme assay 
Protein synthesis in the reticulocyte lysate 
system: [‘4C]leucine incorporation into protein 
was carried out in the standard lysate assay system 
derived from rabbit reticulocytes as reported [14] 
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except that the total volume was 50 pl containing 
10~1 lysate. [r4C]Leucine was used at 40 Ci/mol; 
incubation was at 37°C for 15 min unless stated 
otherwise. 
3. RESULTS AND DISCUSSION 
Protein synthesis in the heme-supplemented 
reticulocyte lysate assay system is inhibited by the 
addition of small amounts of P-spectrin but not by 
the (cu#) heterodimer as shown in fig. 1. Under the 
conditions used half-maximum inhibition is caused 
by less than 0.2/rg highly purified @-spectrin 
prepared by either of the procedures described 
above. In the same figure the inhibitory effect of 
the reticulocyte heme-controlled eIF-2cu kinase is 
shown for comparison. This kinase phosphorylates 
the cy- or smallest subunit of peptide initiation fac- 
tor 2, eIF&, and thereby inhibits binding of Met- 
tRNAf to 40 S ribosomal subunits [15] apparently 
by preventing the exchange of GTP for GDP from 
the GDP - eIF-2 complex [16]. On the basis of the 
weight of protein added to the lysate reaction mix- 
ture &spectrin is about half as inhibitory as the 
kinase, as judged from the initial slope of the in- 
hibition curves. To a first approximation, half- 
maximum inhibition occurs at a ,&spectrin to 
ribosome molar ratio of about 1: 5, assuming an 
MI of 220000 for&spectrin and 20 pg ribosomes in 
K 2Or- 
t 0 I 0 .2 .4 .6 
PROTEIN ADDED. u9 
Fig.1. Inhibition of protein synthesis by ,&spectrin. fl- 
Spectrin (M) or ((r.J) heterodimeric spectrin 
(W), or highly purified heme-regulated eIF-2cu 
kinase (O--O) was added to the reticulocyte lysate 
reaction mixture in the amounts indicated. Leucine 
incorporated into protein in the presence of 2 x 10e6 M 
edeine (- - -) is shown for comparison. 
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Table 1 
No effect of fi-spectrin on poly(U)-directed 
pol~henylalanine synthesis 
P-Spectrin [r4C]Phenylalanine % 
tug) incorporated (cpm) 
None 2227 loo 
0.1 2201 99 
0.2 2199 99 
0.4 2230 100 
0.8 2158 97 
1.2 2226 100 
The assay system has heen referenced in section 2. & 
Spectrin was added in amounts indicated followed by a 
10 min incubation at 37°C 
the lysate reaction mixture. Neither p7-spectrin or 
the kinase inhibits the lysate system below the level 
caused by edeine, a peptide antibiotic that binds to 
40 S ribosomal subunits and has specificity for in- 
hibition of peptide initiation [ 131. Neither ,& 
spectrin nor the eIF-2a! kinase inhibits the elonga- 
tion of previously initiated, nascent peptides in the 
presence of edeine (not shown). Regulin [10,17], 
another membrane skeletal protein with size and 
physical properties similar to those of &spectrin, 
did not inhibit protein synthesis in the lysate 
system (not shown). The effect of tu-spectrin was 
not determined. Neither method used for ,& 
spectrin isolation gave satisfactory purification of 
the spectrin cr-subunit. 
The results described above suggest hat the in- 
hibition by &spe.ctrin is at the level of peptide in- 
itiation with little or no effect on peptide elonga- 
tion. This conclusion is supported by data ob- 
tained for poly(U)-dir~ed polyphenyl~~ne syn- 
thesis (cf. [IS]). ,&Spectrin in amounts up to 
6-times greater than required for half-m~imum 
inhibition of the lysate system did not inhibit 
polyphenylalanine synthesis. Peptide synthesis in 
this system involves the enzymes of peptide elonga- 
tion whereas most of the steps of peptide initiation 
with natural mRNA are circumvented. 
Time courses for leucine incorporation into pro- 
tein in uninhibited and the @-spectrin or eIF-2a! 
kinase inhibited lysate systems are shown in fig.2. 
Peptide synthesis in the presence of the kinase is 
Iinear and at the rate of the uninhibited control for 
the first minutes of the reaction, then the rate 
“0 5 10 15 20 
TIME. min 
Fig.2. Kinetics of protein synthesis n the presence of fl- 
spectrin or the eIF-2cu kinase. The time course of leucine 
incor~ration into peptide was determined from 4501~1 
lysate reaction mixtures in the absence (W-H) or 
presence of 0.17 yg P-spectrin (~1 or 0.09 fig heme- 
sensitive IF-ti kinase (O-Q). Aliquots of 50~1 were 
withdrawn from the reaction mixture at the times 
indicated. 
abruptly decreases to a very low level. These 
unusual but very characteristic kinetics for inhibi- 
tion by the eIF& kinase (cf. [ 191) are not seen 
with@-spectrin and point to a different mechanism 
of inhibition. This conclusion is supported by the 
data presented in table 2. Inhibition caused by the 
eIF-2cu kinase can be overcome by the addition of 
exogenous eIF-2 to the lysate reaction mixture 
[20]. Although increased leucine incorporation oc- 
curs with the addition of exogenous eiF-2 to the 
lysate system, the percent of inhibition caused by 
Table 2 
No compensatory effect of eIF-2 or hemin on spectrin 
inhibition 
Additions [‘4C]Leucine in- Inhibi- 
corporated (cpm) tion 
@Jo) 
Control f B-spectrW 
None 13034 8070 38 
(A) 0.8 &g eIF-2 14236 8960 37 
4.0 pg eIF-2 16230 10110 38 
(Bf 0.5 fig hemin 10678 6594 38 
15.0 pg hemin 7712 5100 34 
’ 0.18 pg P-spectrin was added 
273 
Volume 200, number 2 FEBS LETTERS May 1986 
0.18 gg ,&spectrin is constant with increasing 
amounts of eIF-2. These results appear to indicate 
that inhibition by 8-spectrin cannot be reversed by 
eIF-2 and are consistent with the hypothesis that ,8- 
spectrin inhibition does not involve an eIF-2cu 
kinase. Also included in table 2 are results showing 
that P-spectrin inhibition cannot be overcome by 
additional heme. This type of experiment was 
prompted by recently published data [21] in which 
heme was found to have an effect on the aggrega- 
tion state of spectrin; ,&spectrin is known to self- 
aggregate [ 111. 
Although the physiological significance of the 
observations presented above remains to be 
established, the data indicate that fl-spectrin is a 
potent inhibitor of protein synthesis in the 
reticulocyte lysate system at some point during 
peptide initiation. The amounts of ,&spectrin re- 
quired for inhibition suggest that a catalytic 
mechanism may be involved. However, generally 
spectrin is considered to be a structural protein 
with no known enzymatic activity. We suggest hat 
the results presented above may reflect binding to 
fl-spectrin and thereby direct or indirect inactiva- 
tion of a factor other than eIF-2 that is required 
for peptide initiation in the reticulocyte lysate 
system. 
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